另外，公司拟1000万元至2000万元回购股份，用于股权激励或员工持股计划，回购股份价格不超过 139.77元/股(含)。 人民财讯9月26日电，博瑞医药(688166)9月26日公告，公司拟发行H股股票并在香港联交所主板上市。 ...

Group 1 - The core point of the article is that Borui Pharmaceutical plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance overseas business layout [1] - The company aims to improve its overseas financing capabilities, capital strength, and overall competitiveness through this issuance [1] - The timing and details of the issuance are still under discussion with relevant intermediaries, and the process is subject to approvals from government agencies, regulatory bodies, and the stock exchange [1]

博瑞医药公告，拟以1000万元-2000万元回购公司股份，回购价格不超过139.77元/股。此次回购股份将 用于股权激励或员工持股计划，预计回购股份数量为7.15万股-14.31万股，占公司总股本的 0.02%-0.03%。回购资金来源为公司自有资金，回购期限为自董事会审议通过之日起12个月内。 ...

Core Viewpoint - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance overseas business development, aiming to improve its capital strength and overall competitiveness [1] Group 1 - The company will hold the 12th meeting of the 4th Board of Directors and the 10th meeting of the 4th Supervisory Board on September 26, 2025 [1] - The proposals under review include the issuance of H-shares and the plan for listing on the main board of the Hong Kong Stock Exchange [1] - The company intends to consider the interests of existing shareholders and market conditions when determining the timing for the issuance and listing [1]

博瑞医药公告，先进制造产业投资基金于2025年6月30日～2025年9月22日通过集中竞价减持421.61万 股，占1.00%；通过大宗交易减持108.57万股，占0.26%；合计减持530.18万股，占1.25%，减持价格区 间53.08～122.01元/股，减持金额4.41亿元；目前持股1331.11万股，占3.15%。 ...

博瑞医药公告，全资子公司博瑞生物医药泰兴市有限公司拟与苏州信博瑞投资有限公司签署《增资协 议》。苏州信博瑞拟以人民币1.98亿元认购博瑞泰兴新增注册资本2268.05万元，其余1.75亿元计入博瑞 泰兴资本公积，公司放弃本次增资的优先认购权。本次增资完成后，博瑞泰兴的注册资本将由5500万元 增加至7768.05万元，公司直接持有博瑞泰兴的股权比例将由100%变更为70.80%，博瑞泰兴仍属于公司 合并报表范围内的控股子公司。本次交易不构成关联交易，亦不构成《上市公司重大资产重组管理办 法》规定的重大资产重组。本次交易已经公司第四届董事会第十二次会议审议通过，无需提交公司股东 大会审议。 ...

9月26日，博瑞医药大宗交易成交4.5万股，成交额261.27万元，占当日总成交额的0.17%，成交价58.06元，较市场收盘价58.06元持平。 | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2025-09-26 | 博瑞医药 | 688166 | 58.06 261.27 | 4.5 | 电万泰源证券息紧 | 国联民生证券股份 有限公司总部 | ...

中国经济网北京9月26日讯博瑞医药(688166.SH)股价今日下跌，截至收盘报58.06元，跌幅12.57%。 东吴证券股份有限公司研究员朱国广9月16日发布研报《博瑞医药(688166)：BGM0504片剂中美均进入I 期临床在研管线顺利推进》称，维持博瑞医药"买入"评级。 ...

Market Overview - A-shares fell on September 26, with the ChiNext Index dropping over 2% and the Hang Seng Index declining more than 1% [1] - The total trading volume in the Shanghai and Shenzhen markets was 21,664 billion yuan, a decrease of 2,256 billion yuan from the previous day [1] Pharmaceutical Sector - The pharmaceutical sector experienced a significant decline, with stocks like Guangsheng Tang dropping nearly 15% and others like Xiangrikui and Borui Pharmaceutical falling over 10% [3][4] - Borui Pharmaceutical has seen a cumulative drop of nearly 40% over the past five trading days, despite the company stating that its operations remain normal and there are no significant changes in market conditions [4][3] Semiconductor Sector - The semiconductor sector also faced a downturn, with stocks such as Lianang Microelectronics hitting the daily limit down and others like Dongwei Semiconductor and Gai Lun Electronics dropping over 6% [7][8] - Reports indicate that the Trump administration is considering a new semiconductor policy that could impose a 100% tariff on companies that do not maintain a 1:1 ratio of domestically produced to imported semiconductors [8][7] Wind Power Sector - The wind power sector showed resilience, with stocks like Weili Transmission and Huazi Technology hitting the daily limit up, and overall wind power capacity in China growing by 22.1% year-on-year [11][12] - The National Energy Administration reported that as of the end of August, the cumulative installed power generation capacity reached 3.69 billion kilowatts, with solar power capacity increasing by 48.5% [12][11] Market Sentiment - The overall market sentiment was negative, with over 3,400 stocks declining, particularly in the pharmaceutical and semiconductor sectors, while the wind power sector thrived amid positive policy expectations [1][10]

Market Overview - A-shares experienced a decline on September 26, with the ChiNext Index dropping over 2% and the Hang Seng Index falling more than 1% [1] - The Shanghai Composite Index closed down 0.65% at 3828.11 points, while the Shenzhen Component Index fell 1.76% to 13209 points [1] - The total trading volume in the three markets (Shanghai, Shenzhen, and Beijing) was 216.64 billion yuan, a decrease of 22.56 billion yuan from the previous day [1] Pharmaceutical Sector - The pharmaceutical sector saw significant declines, with stocks like Guangsheng Tang dropping nearly 15% and Xiangrikui and Borui Pharmaceutical falling over 10% [3][4] - Borui Pharmaceutical has accumulated a nearly 40% drop over the last five trading days, despite the company stating that its daily operations remain normal and there have been no significant changes in market conditions [4][5] Semiconductor Sector - The semiconductor sector also faced a downturn, with stocks such as Lianang Microelectronics hitting the daily limit down and others like Dongwei Semiconductor and Gai Lun Electronics dropping over 6% [8][9] - Reports indicate that the Trump administration is considering a new semiconductor policy that could impose a 100% tariff on companies that do not maintain a 1:1 ratio of domestically produced to imported semiconductors [9][10] Wind Power Sector - The wind power sector showed resilience, with stocks like Weili Transmission and Huazi Technology hitting the daily limit up, and others like Taiyuan Heavy Industry and Xiangdian Co. also reaching their limits [12][13] - The National Energy Administration reported that as of the end of August, the cumulative installed capacity of wind power reached 580 million kilowatts, a year-on-year increase of 22.1% [12][14] - The acceleration of domestic offshore wind projects and favorable policies are expected to support the growth of the wind power sector, with major companies actively expanding into overseas markets [14]